Science Explorer Back to mapMap
Discussion
Researcher · Mount Vernon Cancer Centre · United Kingdom

Paul Nathan

Paul Nathan publishes mostly in Oncology, Molecular Biology and Pulmonary and Respiratory Medicine, on topics such as Melanoma and MAPK Pathways, Renal cell carcinoma treatment and Cancer Immunotherapy and Biomarkers.

ORCID 0000-0002-2327-3250 OpenAlex
World rank
#130,485
of 7,710,434 ranked researchers
Rank in United Kingdom
#11,694
of 367,258
Works
462
Citations
31k
Citations per work
68.0
h-index
71
i10-index 211Top 1.3% in Oncology
Paul Nathan

What does Paul Nathan research?

Paul Nathan's work is mostly in Medicine (36%), Biochemistry, Genetics and Molecular Biology (21%), Immunology and Microbiology (6%).

Health Sciences: 169 works · 36.5% of their workMedicine: 169 works · 36.5% of their workOncology: 94 works · 20.3% of their workPulmonary and Respiratory Medicine: 53 works · 11.5% of their workSurgery: 22 works · 4.7% of their workEverything else: 168 works · 36.4% of their workLife Sciences: 125 works · 27.1% of their workBiochemistry, Genetics and Molecular Biology: 97 works · 21.0% of their workMolecular Biology: 78 works · 16.9% of their workCancer Research: 19 works · 4.1% of their workImmunology and Microbiology: 28 works · 6.1% of their workImmunology: 28 works · 6.1% of their workTHEIR WORKPaul Nathan462works
Life Sciences27%Health Sciences36%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine16936.5%
  2. Everything else16836.4%
    1. Biochemistry, Genetics and Molecular Biology9721.0%
    2. Immunology and Microbiology286.1%
  1. 1Oncology20% of their works
  2. 2Molecular Biology17% of their works
  3. 3Pulmonary and Respiratory Medicine12% of their works
  4. 4Immunology6% of their works
  5. 5Surgery5% of their works
  6. 6Cancer Research4% of their works

Research topics

Which keywords describe Paul Nathan's research?

The keywords of their largest research topics: Immunotherapy, Melanoma, Genetic Mutations, Prognostic Factors, BRAF gene, MAP Kinase, Metastatic and Renal Cell Carcinoma.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 21 words, with their numbers
  1. Immunotherapy2033 topics
  2. Melanoma1692 topics
  3. Genetic Mutations1392 topics
  4. Prognostic Factors1392 topics
  5. BRAF gene991 topic
  6. MAP Kinase991 topic
  7. Metastatic951 topic
  8. Renal Cell Carcinoma951 topic
  9. Cancer Immunotherapy842 topics
  10. Immune Checkpoint Blockade771 topic
  11. PD-1 and PD-L1771 topic
  12. Dermoscopy701 topic
  13. Skin Cancer701 topic
  14. Dendritic Cells461 topic
  15. Immunity461 topic
  16. Retinoblastoma441 topic
  17. Uveal Melanoma441 topic
  18. CAR T Cells381 topic
  19. Chimeric Antigen Receptor381 topic
  20. Cancer Genomics371 topic
  21. Mutational Signatures371 topic

Where does Paul Nathan work?

Paul Nathan's main affiliation in the publication record is Mount Vernon Cancer Centre, United Kingdom.

How many publications and citations does Paul Nathan have?

OpenAlex counts 462 works and 31,405 citations for Paul Nathan, an h-index of 71, ranking #130,485 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Paul Nathan. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.